Nat. Biotechnol. 23, 517 (2005)

The interview suggested that Julian Thurston was a nonexecutive director of The Cancer Research Campaign. Although Julian Thurston served as a nonexecutive director of Cancer Research Campaign Technology Limited for several years and then of Cancer Research Ventures Limited (which undertook technology transfer services on behalf of The Cancer Research Campaign, now carried out by Cancer Research Technology Limited) until September 2002, he was never a director or trustee of The Cancer Research Campaign. The Cancer Research Campaign merged with the Imperial Cancer Research Fund in February 2002 to form Cancer Research UK. In addition, the text mentions that Julian Thurston started his career as general counsel for what was once the flagship of UK biotech—Celltech, now part of Belgian mid-sized pharma company UCB. It should have read “Julian Thurston started his career at McKenna & Co. and during most of the 1980s with his team provided all the legal support to the firm's first biotech client, Celltech, once the flagship of UK biotech, now part of Belgian mid-sized pharma company UCB.”